Calpain inhibition impairs glycogen syntheses in HepG2 hepatoma cells without altering insulin signaling

Journal of Endocrinology

Volumn 193, Issue 1, 2007, Pages 45-51

  Meier, Markus ^c   Klein, Herald H ^a   Kramer, Jan ^c   Drenckhan, Maren ^c   Schütt, Morten ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Curschmann Klinik   (Germany)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CALPAIN I; CALPAIN II; CALPASTATIN; GLYCOGEN SYNTHASE; INSULIN; INSULIN RECEPTOR KINASE; INSULIN RECEPTOR SUBSTRATE 1; PD 151746; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE EPSILON; THREONINE; UNCLASSIFIED DRUG;

ARTICLE; CELL STIMULATION; CELL STRAIN HEPG2; CONTROLLED STUDY; ENZYME ACTIVITY; GLYCOGEN SYNTHESIS; HEPATOMA CELL; HUMAN; HUMAN CELL; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACRYLATES; ANDROSTADIENES; CALPAIN; CELL LINE, TUMOR; GLYCOGEN; HUMANS; INSULIN; LIVER; PHOSPHOPROTEINS; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 34247393340     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.07087     Document Type: Article

References (31)

1. Andersen JN, Elson A, Lammers R, Romer J, Clausen JT, Moller KB & Moller NP 2001 Comparative study of protein tyrosine phosphatase-epsilon isoforms: membrane localization confers specificity in cellular signalling. Biochemical Journal 354 581-590.
2. Baier LJ, Permana PA, Yang X, Pratley RE, Hanson RL, Shen GQ, Mott D, Knowler WC, Cox NJ, Horikawa Y et al. 2000 A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. Journal of Clinical Investigation 106 R69-R73.
3. Baque S, Guinovart JJ & Ferrer JC 1997 Glyogenin, the primer of glycogen synthesis, binds to actin 1997. FEBS Letters 417 355-359.
4. Bose A, Guilherme A, Robida SI, Nicolori SM, Zhou QL, Jiang ZY, Pormerleau DP & Czech MP 2002 Glucose transporter recycling in response to insulin is facilitated by myosin Myo1c. Nature 420 821-824.
5. Cox NJ, Hayes MG, Roe CA, Tsuchiya T & Bell GI 2004 Linkage of Calpain 10 to type 2 diabetes. The biological rationale. Diabetes 53 (Suppl 1) S19-S25.
6. Gil-Henn H, Volohonsky G & Elson A 2001 Regulation of protein-tyrosine phosphatases α and ε by calpain-mediated proteolytic cleavage. Journal of Biological Chemistry 276 31772-31779.
7. Goll DE, Thompson VE, Li H, Wei W & Cong J 2003 The calpain system. Physiological Reviews 83 731-801.
8. Hofmann C, Marsh JW, Miller B & Steiner DF 1980 Cultured hepatoma cells as a model system for studying insulin processing and biologic responsiveness. Diabetes 29 865-874.
9. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE et al. 2000 Genetic variation in the gene encoding calpain-10 is associated with type-2 diabetes mellitus. Nature Genetics 26 163-175.
10. Huang D, Cheung AT, Parsons JT & Bryer-Ash M 2002 Focal adhesion kinase (FAK) regulates insulin-stimulated glycogen synthesis in hepatocytes. Journal of Biological Chemistry 277 18151-18160.
11. Klein HH, Kowalewski B, Drenckhan M, Neugebauer S, Matthaei S & Kotzke G 1993 A microtiter well assay system to measure insulin activation of insulin receptor kinase in intact human mononuclear cells. Diabetes 42 883-890.
12. Klein HH, Vestergaard H, Kotzke G & Pedersen O 1995 Elevation of serum insulin concentration during euglycemic hyperinsulinemic clamp studies leads to similar activation of insulin receptor kinase in skeletal muscle of subjects with or without NIDDM. Diabetes 44 1310-1317.
13. Kolter T, Uphues I & Eckel J 1997 Molecular analysis of insulin resistance in isolated ventricular cardiomyocytes of obese Zucker rats. American Journal of Physiology Endocrinology and Metabolism 273 E59-E67.
14. Lynn S, Evans JC, White C, Frayling TM, Hattersley AT, Turnbull DM, Horikawa Y, Cox NJ, Bell GI & Walker M 2002 Variation in the calpain-10 gene affects blood glucose levels in the British population. Diabetes 51 247-250.
15. Malecki MT, Moczulski DK, Klupa T, Wanic K, Cyganek K, Frey J & Sieradzki J 2002 Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population. European Journal of Endocrinology 146 695-699.
16. Mazeres G, Leloup L, Daury L, Cottin P & Brustis JJ 2006 Myoblast attachment and spreading are regulated by different patterns by ubiquitous calapains. Cell Motility and the Cytoskeleton 63 193-207.
17. Meyer MM, Levin K, Grimmsmann T, Beck-Nielsen H & Klein H 2002 Insulin signalling in skeletal muscle of subjects with or without type II-diabetes and first degree relatives of patients with the disease. Diabetologia 45 813-822.
18. Nakagawa Y, Aoki N, Aoyama K, Shimizu H, Shimano H, Yamada N & Miyazaki H 2005 Receptor-type protein tyrosine phosphatase epsilon (PTPepsilonM) is a negative regulator of insulin signaling in primary hepatocytes and liver. Zoological Science 22 169-175.
19. Otani K, Polonsky KS, Holloszy JO & Han DH 2006 Inhibition of calpain results in impaired contraction-stimulated GLUT4 translocation in skeletal muscle. American Journal of Physiology, Endocrinology and Metabolism 16 (Epub ahead of print).
20. Parnaud G, Hammar E, Rouiller DG & Bosco D 2005 Inhibition of Calpain blocks pancreatic β-cell spreading and insulin secretion. American Journal of Physiology, Endocrinology and Metabolism 289 E544-E548.
21. Patel S, Doble B & Woodgett JR 2004 Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword? Biochemical Society Transaction 32 803-808.
22. Paul DS, Harmon AW, Winston CP & Patel YM 2003 Calpain facilitates GLUT4 vesicle translocation during insulin-stimulated glucose uptake in adipocytes. Biochemical Journal 376 625-632.
23. Pirola L, Johnston AM & Van Obberghen E 2004 Modulation of insulin action. Diabetologia 47 170-184.
24. Prats C, Cadefau JA, Cusso R, Qvortrup K, Nielsen JN, Wojtaszewski JF, Hardie DG, Stewart G, Hansen BF & Ploug T 2005 Phosphorylation-dependent translocation of glycogen synthase to a novel structure during glycogen resynthesis. Journal of Biological Chemistry 280 23165-23172.
25. Qiu W, Avramoglu RK, Dube N, Chong TM, Naples M, Au C, Sidiropoulos KG, Lewis GF, Cohn JS, Tremblay ML et al. 2004 Hepatic PTP-1B expression regulates the assembly and secretion of apolipoprotein B-containing lipoproteins: evidence from protein tyrosine phosphatase-1B overexpression, knockout, and RNAi studies. Diabetes 53 3057-3066.
26. Raser KJ, Posner A & Wang KK 1995 Casein zymography: a method to study m-calpain, and their inhibitory agents. Archives of Biochemistry and Biophysics 319 211-216.
27. Roig J, Krehan A, Colomer D, Pyerin W, Itarte E & Plana M 1999 Multiple forms of protein kinase CK2 present in leukemic cells: in vitro study of its origin by proteolysis. Molecular and Cellular Biochemistry 191 229-234.
28. Schütt M, Meier M, Meyer M, Klein J, Aries SP & Klein HH 2000 The HIV-1 protease inhibitor indinavir impairs insulin signaling in HepG2 hepatoma cells. Diabetologia 43 1145-1148.
29. Sreenan SK, Zhou YP, Otani K, Hansen PA, Currie KP, Pan CY, Lee JP, Ostrega DM, Pugh W, Horikawa Y et al. 2001 Calpains play a role in insulin secretion an action. Diabetes 50 2013-2020.
30. Vaag A, Henriksen JE & Beck-Nielson H 1992 Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation 89 782-788.
31. Yang X, Pratley RE, Baier LJ, Horikawa Y, Bell GI, Bogardus C & Permana PA 2001 Reduced skeletal muscle calpain-10 transcript level is due to a cumulative decrease in major isoforms. Molecular Genetics and Metabolism 73 111-113.